Jefferies Starts Novavax (NVAX) at Buy, $200 PT; Set to Become Major COVID-19 Vaccine Player
Go back to Jefferies Starts Novavax (NVAX) at Buy, $200 PT; Set to Become Major COVID-19 Vaccine Player| Novavax, Inc. (NASDAQ: NVAX) | Delayed: 8.88 +0.32 (3.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.56 | 52 Week High | $9.23 | |||
| Open | $8.53 | 52 Week Low | $1.16 | |||
| Day High | $8.94 | P/E | N/A | |||
| Day Low | $8.53 | EPS | $-0.30 | |||
| Volume | 8,409,084 | |||||

